Edegem

• A Study of abemaciclib Combined with Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer Ended recruitment
  2023-506781-30-00 5 2014-09-17 Breast cancer
• Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended recruitment
  2024-511096-15-00 5 2014-08-01 Breast Cancer
• CATALINA-2: A Phase 2 Study of TORL-1-23 in Advanced Ovarian Cancer Halted
  2024-517190-24-00 4 2025-09-16 Peritoneal Cancer
• A Phase 1, Open-Label, Multicenter Study of INCB161734 in Participants With Advanced or Metastatic Solid Tumors with KRAS G12D Mutation Halted
  2023-507091-47-00 1 2025-02-10 Advanced or metastatic solid tumors
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-6404 … Halted
  2023-505096-68-00 4 2025-01-14 Preclinical Alzheimer’s Disease
• A Phase 3 Study of NTLA 2001 in participants with amyloidosis with cardiac muscle disease. Halted
  2023-507220-23-00 5 2024-07-26 Transthyretin Amyloidosis with Cardiomyopathy
• A Phase 1 Study of CD19-targeted NEX-T CAR T Cells in Participants with RMS, PMS, or MG(Breakfree-2) Halted
  2023-507820-22-00 3 2024-05-22 Progressive Multiple Sclerosis (PMS)
• Phase IV multicenter trial to evaluate the immunogenicity and safety of the Seqirus licensed zoonotic influenza vaccine (H5N8) in adults pre … Ended
  2025-522116-16-00 6 2025-12-08 Avian Influenza
• A clinical study of MK-6050 in healthy people (MK-6050-001) Ended
  2025-523861-58-00 1 2025-11-24 Hidradenitis suppurativa
• A study to assess the immune response and safety of a vaccine against influenza in adults 18 years of age and older Ended
  2025-522599-97-00 4 2025-10-30 Influenza, Human
• A First-in-human study to learn how safe the study drug BAY2965501 is, find the best dose (single drug & combination), how it affects the bo … Ended
  2023-507905-33-00 1 2025-09-30 Advanced solid tumors
• Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, immunogenicity and safety of one dose of … Ended
  2024-520354-37-00 4 2025-09-08 Influenza disease
• A study to Learn How Safe AGMB-129 is in Healthy Adults Taking Multiple Doses of AGMB-129 That Are Increased a Little at a Time Ended
  2025-521705-40-00 3 2025-07-18 Fibrostenotic Crohn’s disease
• Study to Learn How Safe EV25 is and the Amount of EV25 in the Body Over a Period of Time, When Taken [CCI] as a Dry Powder via the Nose by A … Ended
  2025-521783-35-00 3 2025-07-10 Influenza virus
• Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents with Sickle Cell Disease during Vaso-Occlusive Crisis Ended
  2024-513440-29-00 10 2025-06-25 Sickle cell disease vaso-occlusive crisis
• A Study to Learn How Safe Different Doses of NTS-521 are, What the Amount of NTS-521 in the Body is Over a Period of Time, and What the Effe … Ended
  2024-518613-26-01 1 2025-06-06 Not applicable
• A study to investigate how different tablet types of balinatunfib and food will influence the absorption of balinatunfib in blood in healthy … Ended
  2024-519860-41-00 3 2025-06-02 Immune system diseases
• A study to test how well multiple doses of BI 3810477 are tolerated by healthy adults. Ended
  2024-519327-20-00 3 2025-05-21 Healthy volunteer trial
• A phase 4, open-label study to evaluate the short-term innate immune response after administration of a COVID-19 mRNA vaccine (Comirnaty JN … Ended
  2024-520304-26-00 6 2025-05-05 COVID-19
• Drug-Drug Interaction Study With BIA 28-6156 and Clarithromycin, Midazolam, and Dabigatran Etexilate in Healthy Participants Ended
  2025-520840-14-00 3 2025-04-29 Healthy volunteers
• A clinical study of MK-1403 in healthy people (MK-1403-002) Ended
  2023-507239-39-00 3 2025-04-25 Atherosclerosis
• A trial to learn how safe AZD0022 is, how well it works, and how it moves throughout the body over time in adults with tumors that have a KR … Ended
  2024-516699-14-00 7 2025-04-23 Non Small Cell Lung Cancer Colorectal Cancer Pancreatic Ductal Adenoca
• Study to test new drug eftilagimod alfa (also known as efti) combined with standard marketed treatments (pembrolizumab and chemotherapy) in … Ended
  2024-513621-23-00 5 2025-04-18 Advanced/metastatic non-small cell lung cancer (NSCLC)
• A study to investigate the bioavailability of the SAR444656 test formulation and the food effect on the SAR444656 test formulation in health … Ended
  2024-515621-28-00 3 2025-04-17 Healthy Volunteer

Showing 409–432 of 590 trials